Envisioning the site of the future

Monday, May 1, 2017

The drug development world has been notoriously slow to adopt change, but industry leaders and visionaries expect the clinical research enterprise to change dramatically.
Integration of healthcare data, the power of data and analytics, a rapid move toward more targeted therapies and customized treatments, along with the desire for a lower cost R&D model are among the forces driving transformation in the way the research environment will function in the future.

[Read More]

The CenterWatch Weekly, November 21, 2016

Monday, November 21, 2016

DrugDev acquires SecureConsent

DrugDev has acquired SecureConsent, an electronic informed consent (eConsent) pro­vider, in a move that expands the company’s suite of technology offerings designed to improve the efficiency of clinical operations at investigative sites. No financial terms of the deal were disclosed.

New specialty IRB targets social science research

A major provider of clinical research support services has launched a new institutional review board (IRB) focused entirely on social science research. The Biomedical Research Alliance of New York (BRANY), a network of four medical centers with over 200 affiliated study sites, now of­fers centralized IRB services from a panel of academic experts in social, behavioral and educational research (SBER). The new SBER IRB includes epidemiologists, psychologists and social workers, and represents an expansion of BRANY’s existing IRB services.


To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

Laura Donohue joins BRANY’s IRB team

Tuesday, February 2, 2016

Laura Donohue has joined Biomedical Research Alliance of New York (BRANY), a national organization providing support services to sponsors and investigators involved in research, as IRB supervisor. She will work with BRANY’s central, AAHRPP-accredited IRB.

[Read More]

BRANY solution takes two 2015 app design awards

Thursday, October 8, 2015

ProtocolBuilder, a first-of-its-kind solution for writing clinical trial protocols, has received Gold Awards for “Best New Service Award or Application” and “Health Application” in the 2015 [app] design awards sponsored by design100. The awards celebrate creativity and innovation in design achievements by app creators and commissioners.

[Read More]

BRANY launches new license option for Protocol Builder

Friday, August 14, 2015

Protocol Builder, a cloud-based solution for investigator-initiated clinical trials, now is available to individual researchers, including medical residents and fellows, according to the Biomedical Research Alliance of New York (BRANY), the developer of the system and a national organization providing clinical research support solutions such as IRB review, trial contracting/budgeting, and auditing and monitoring to hospitals and academic medical centers.

[Read More]